The DoD Peer Reviewed Cancer Research Program Translational Team Science Award supports translational correlative studies associated with an existing clinical trial and/or translational study that can lead to a future clinical trial or clinical application in cancer research that is relevant to Service Members, their families, and other military beneficiaries.
To be considered for funding, applications must address at least one of the Topic Areas. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.
- Colorectal cancer
- Genetic cancer
- Kidney cancer
- Listeria vaccine for cancer
- Liver cancer (New for FY15)
- Melanoma and other skin cancers
- Myeloproliferative disorders
- Pancreatic cancer
- Stomach cancer (new for FY15)
Funding & Duration
Maximum funding for the entire period of performance is US$1,200,000 for direct costs (plus indirect costs). Maximum period of performance is 3 years.
At least three and up to five Principal Investigators across at least two institutions must partner in one overarching correlative or translational research study.
At least one Early Career Investigator within 10 years of completing a terminal degree (excluding time in residency or on family medical leave, and/or one military/Department of Veterans Affairs investigator must be included as an equal partner in the research offering both intellectual investment and research effort.
Pre-Application must be submitted to the Research Branch for internal review by 9 June 2015. Application submission is by invitation only. Application due for internal review: 22 September 2015.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org
Applications must be submitted through the federal government’s single-entry portal, Grants.gov.
Submitted applications must be accompanied by a signed and completed copy of the University’s Grant Application Cover Sheet. Submissions may be emailed to the Research Branch unless otherwise specified.
Grants Officer: Dr Don McMaster